« Back to Record
Citation APA

Loi, S., Salgado, R., Piette, F., Sirtaine, N., Van Eenoo, F., Kammler, R., Rouas, G., Francis, P., Crown, J., Nordenskjöld, B., Gutierrez, J., Andersson, M., Vila, M. M., Jakesz, R., Viale, G., Quinaux, E., Di Leo, A., Michiels, S., Sotiriou, C., & Piccart-Gebhart, M. (2011). Evaluation of the prognostic and predictive value of tumor-infiltrating lymphocytes (TILs) in a phase III randomized adjuvant breast cancer (BC) trial (BIG 2-98) of node-positive (N1) BC comparing the addition of docetaxel to doxorubicin (A-T) with doxorubicin (A)-only chemotherapy (CT). Poster session presented at ASCO Annual Meeting (2011-06: Chicago, USA).


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/244758

Loi, S., Salgado, R., Piette, F., Sirtaine, N., Van Eenoo, F., Kammler, R., Rouas, G., Francis, P., Crown, J., Nordenskjöld, B., Gutierrez, J., Andersson, M., Vila, M. M., Jakesz, R., Viale, G., Quinaux, E., Di Leo, A., Michiels, S., Sotiriou, C., & Piccart-Gebhart, M. (2011). Evaluation of the prognostic and predictive value of tumor-infiltrating lymphocytes (TILs) in a phase III randomized adjuvant breast cancer (BC) trial (BIG 2-98) of node-positive (N1) BC comparing the addition of docetaxel to doxorubicin (A-T) with doxorubicin (A)-only chemotherapy (CT). Poster session presented at ASCO Annual Meeting (2011-06: Chicago, USA).